Type 1 vs type 2 diabetes: cause, onset, ketosis risk and treatment

Lead with insulin production, not age

The most useful distinction is whether the pancreas still makes insulin. In type 1 diabetes, an autoimmune process destroys beta cells, and insulin production falls to very low levels. In type 2 diabetes, cells respond poorly to insulin and the pancreas eventually cannot keep up. This difference explains why daily insulin is essential in type 1 and only sometimes needed in type 2.

Age is a weaker clue than many candidates assume. Type 1 is often diagnosed in children and young adults but can appear at any age, and type 2 is increasingly seen in younger people. Exam stems may mention autoantibodies or low C-peptide, which point toward type 1, or obesity, family history and a sedentary lifestyle, which suggest type 2.

Contrast the speed of onset and presentation

Type 1 symptoms can appear over a few weeks or months and may be severe at diagnosis, sometimes presenting as ketoacidosis with vomiting, abdominal pain, deep rapid breathing and dehydration. Weight loss despite normal eating is a common early sign because the body breaks down fat and muscle when glucose cannot enter cells without insulin.

Type 2 usually develops over years and may cause no noticeable symptoms for a long time, so it is often found through screening or when complications appear. A patient may first present with recurrent infections, slow wound healing or blurred vision. This slow course is why risk-based screening and prevention teaching feature in type 2 questions.

Match each type to its acute hyperglycaemic emergency

Diabetic ketoacidosis is classically associated with type 1, because severe insulin deficiency allows fat breakdown and ketone production, leading to metabolic acidosis. Triggers include missed insulin, infection and new diagnosis. Nursing priorities are fluid replacement, prescribed insulin infusion, potassium monitoring and frequent glucose checks according to protocol. Ketoacidosis can occur in type 2 under stress, so avoid absolute statements.

Hyperosmolar hyperglycaemic state is more common in type 2, often in older adults with infection, limited fluid intake or poor kidney function. Glucose is extremely high and dehydration severe, but ketones are absent or mild because some insulin remains. Altered mental status is common. Fluid replacement and close neurological, glucose and electrolyte monitoring are priorities.

Tailor treatment and teaching to the type

For type 1, teaching centres on insulin as a lifelong requirement: injection or pump technique, glucose monitoring, recognising hypoglycaemia, and sick day rules that stress continuing insulin even when eating less. Patients should learn when to check ketones and when to seek urgent help. Stopping insulin because of reduced appetite is a dangerous misconception to correct.

For type 2, teaching emphasises healthy eating, physical activity and weight management alongside any prescribed medicines. Explain that needing insulin later reflects disease progression rather than personal failure. Both groups benefit from foot care, eye examinations and cardiovascular risk reduction, so long-term complication teaching overlaps even though the daily treatment plans differ.

Practice with an original comparison scenario

Imagine two hypothetical patients. A 16-year-old has lost weight over six weeks, is vomiting and breathing deeply. A 74-year-old with known type 2 diabetes and pneumonia is confused, with very high glucose and dry mucous membranes but no significant ketones. Which pairing is most likely: DKA and HHS, HHS and DKA, or both hypoglycaemia? DKA then HHS fits best.

The reversed pairing ignores ketone status, and hypoglycaemia does not fit very high glucose. For the first patient, priorities include fluids, prescribed insulin and potassium monitoring. For the second, cautious but substantial fluid replacement and neurological checks are central. Actual treatment follows prescriber orders and the facility's hyperglycaemic emergency protocol.

Sources and further reading

CDC: Type 1 diabetes. Autoimmune cause, onset at any age, rapid symptom development and daily insulin requirement.

CDC: Type 2 diabetes. Insulin resistance, gradual onset, risk factors, lifestyle and medicine management and prevention.

MedlinePlus: Diabetic hyperglycemic hyperosmolar syndrome. HHS mainly in type 2, very high glucose with absent or mild ketones, dehydration and altered consciousness.

Merck Manual Professional: Type 1 diabetes mellitus. Autoimmune beta cell destruction, autoantibodies, low C-peptide and DKA presentation.